Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.705 USD | +0.56% | -1.99% | -6.40% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
Business Summary
Number of employees: 32
Managers
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 21-07-31 |
Director of Finance/CFO | 52 | Jan. 04 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 23-05-07 |
Robert Macdonald
CTO | Chief Tech/Sci/R&D Officer | 62 | 23-05-07 |
Amresh Kumar
PRN | Corporate Officer/Principal | 44 | 23-05-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 23-10-09 |
Director/Board Member | - | 23-10-09 | |
Santosh Kottayil
BRD | Director/Board Member | - | 23-10-09 |
Chairman | 55 | 21-08-26 | |
Prashant Kohli
CEO | Chief Executive Officer | 52 | 21-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,399,404 | 7,893,546 ( 83.98 %) | 0 | 83.98 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.40% | 25.43M | |
+34.35% | 705B | |
+30.55% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.00% | 238B | |
-3.15% | 210B | |
+10.50% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- ACST Stock
- Company Acasti Pharma Inc.